Mahamaya Lifesciences Ltd Share Price

Agro Chemicals

BSE: 544611 Small Cap ISIN: INE0U9D01019

As on 13 June 2026 at 03:46 IST

Stock Not Traded in BSE

Over 1 Month

-2.06%

Over 6 Months

28.02%

Over 1 Year

51.42%

Over 3 Years

None%

Mahamaya Lifesciences Ltd Summary

Close ₹175.65

Open ₹173.10

High ₹180

Low ₹170.10

Volume 19,200

Net Turnover (in Cr) ₹0.33

52Wk High ₹205.05

52Wk Low ₹111

52Wk High / Low

111

205.05

Mahamaya Lifesciences Ltd Fundamentals

Key Financial Data

Market Cap (in Cr) ₹411.11

EPS (TTM) 7.14

Book Value (BV) 52.39

Div. Yield -

P/E (TTM) 24.60

Price/Book Value 3.35

Delivery % 62.50 %

Face Value 10

Key Ratios

PE Ratio -

PB Ratio -

EV to Sales -

PEG Ratio -

ROA 11.83

ROE 34.16

Debt-Equity 1.50

Net Profit Margin 4.82

Operating Profit Margin 9.73

Mahamaya Lifesciences Ltd Financials

Consolidated

Standalone

Yearly

Quarterly

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022
Total Revenue	267.17	162.83	137.40	90.16
Total Expenses	249.81	155.71	132.30	86.43
Profit Before Tax	17.36	7.12	5.10	3.72
Profit After Tax	12.94	5.22	3.75	2.72
Operating Profit After Depreciation	24.19	13.02	7.95	5.35

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022
Fixed Assets	31.17	24.42	23.55	21.95
Total Non Current Assets	31.62	24.75	23.88	22.39
Total Current Assets	156.73	87.32	54	33.32
Total Assets	188.35	112.07	77.88	55.71
Total Shareholder's Fund	49.42	24.66	19.44	15.71

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022
Net Cash From Operating Activities	0.52	-22.66	1.12	2.16
Net Cash Used In Investing Activities	-8.28	-2	-2.85	-3.25
Net Cash Used In Financing Activities	8.52	24.35	2.36	1.38

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023
Total Revenue	267.17	162.82	137.39
Total Expenses	249.80	155.30	132.18
Profit Before Tax	17.26	7.52	5.21
Profit After Tax	12.82	5.47	3.73
Operating Profit After Depreciation	24.21	12.95	7.82

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023
Fixed Assets	31.17	24.45	23.52
Total Non Current Assets	31.67	24.83	23.89
Total Current Assets	157.04	87.54	54.38
Total Assets	188.71	112.36	78.27
Total Shareholder's Fund	49.87	25.18	19.71

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023
Net Cash From Operating Activities	-3.35	-22.60	0.81
Net Cash Used In Investing Activities	-4.43	-2.24	-2.78
Net Cash Used In Financing Activities	8.47	24.25	2.59

Particulars (in ₹ Cr.)	2025-03	2024-12
Total Revenue	-	-
Total Expenses	-	-
Profit Before Tax	-	-
Profit After Tax	5.40	-
Operating Profit after Depreciation	-	-

No data available

Mahamaya Lifesciences Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 170.50

S2 165.35

S3 160.60

Pivot 175.25

R1 180.40

R2 185.15

R3 190.30

Moving Average

20 SMA 169.52

50 SMA 173.49

100 SMA 171.59

200 SMA -

Mahamaya Lifesciences Ltd Peer Comparison

Company	Price	Market Cap (in Cr)
UPL Ltd	₹594	₹50,127.96
P I Industries Ltd	₹2,800.45	₹42,487.90
Sumitomo Chemical India Ltd	₹447.20	₹22,321.80
Bayer CropScience Ltd	₹4,215.50	₹18,945.34
Sharda Cropchem Ltd	₹875.95	₹7,902.86

Mahamaya Lifesciences Ltd Top Mutal Funds Invested

No data available

Mahamaya Lifesciences Ltd News

Mahamaya Lifesciences to hold board meeting

On 25 May 2026

22 May 2026, 09:38 am

Mahamaya Lifesciences to announce Quarterly Result

On 2 December 2025

27 Nov 2025, 12:13 pm

BSE SME Mahamaya Lifesciences debuts with a modest pulse

Mahamaya Lifesciences traded at Rs 117 on the BSE, a premium of 2.63% compared with the issue price of Rs 114.

18 Nov 2025, 11:10 am

Shares of Mahamaya Lifesciences list in MT Group

18 Nov 2025, 10:07 am

Mahamaya Lifesciences Ltd Stock Analysis

Annual revenue for Mahamaya Lifesciences Ltd increased by 64.09% to ₹267.17 crore in FY 2025 from ₹162.82 crore in FY 2024.
Annual Net Profit for Mahamaya Lifesciences Ltd increased by 134.38% to ₹12.82 crore in FY 2025 from ₹5.47 crore in FY 2024.
Promoter Shareholding in Mahamaya Lifesciences Ltd remains unchanged by 0.00% in the most recent quarter, from 56.35% in November 2025 to 56.35% in March 2026.
Mahamaya Lifesciences Ltd delivered a 1-year return of 51.42% compared to the Nifty 50, which provided a return of -7.87% as of the last trading session.
Mahamaya Lifesciences Ltd share price moved down by 100.00% from its previous close of INR ₹175.65. The latest Mahamaya Lifesciences Ltd share price is INR ₹0.
Mahamaya Lifesciences Ltd share price today has been at a low of 170.10 and a high of 180. Over the past 52 weeks, the Mahamaya Lifesciences Ltd share price has seen a low of 111 and a high of 205.05.